Aquestive presents at H.C. Wainwright conference; no material updates disclosed

Aquestive Therapeutics, Inc.

Investor presentation furnished as Exhibit 99.1; only cover slide text included in filing.
No financial results, pipeline data, or guidance changes provided in the 8-K.
Filing is a routine Regulation FD disclosure for a conference presentation.
No specific numbers, names, or events beyond the presentation's existence.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.